What conditions must a patient meet in order to be reimbursed for Jardiance?

The reimbursement indications are twofold and in each of the two cases quite complex. In general, the drug can be reimbursed in patients with type 2 diabetes or in patients with chronic heart failure, however, it is necessary to meet the following additional criteria: Type 2 diabetes mellitus in patients treated with at least two hypoglycemic drugs, with HbA1c ≥ 7.5% and very high cardiovascular risk understood as: 1) confirmed cardiovascular disease, or 2) damage to other organs manifested by: proteinuria or left ventricular hypertrophy or retinopathy, or 3)the presence of 3 or more of the main risk factors listed below: -age ≥ 55 years for men, ≥60 years for women, -dyslipidaemia, -hypertension, -smoking, -obesity Chronic heart failure in adult patients with reduced left ventricular ejection fraction (LVEF≤40%) and persistent symptoms of disease in NYHA class II-IV despite the use of therapy based on ACEi (or ARB / ARNi) and drugs from the group of beta-blockers and if indicated mineralocorticoid receptor antagonists I enclose additional information about the drug Jardiance and our studies that may be of interest: https://www.gdziepolek.pl/produkty/38817/jardiance-tabletki-powlekane/apteki https://www.gdziepolek.pl/artykuly/ile-kosztuje-zycie-z-cukrzyca https://www.gdziepolek.pl/artykuly/kiedy-lek-nalezy-sie-na-znizke